BioSig Technologies (BSGM)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
CEO:
Kenneth L. Londoner
Employees:
50
8441 WAYZATA BLVD, SUITE 240, MINNEAPOLIS, MN 55426
763-999-7330

BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system. PURE EP is a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition.

Data derived from most recent annual or quarterly report
Market Cap 23.827 Million Shares Outstanding74.927 Million Avg 30-day Volume 300.69 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.06
Price to Revenue336.9042 Debt to Equity0.0 EBITDA-31.291 Million
Price to Book Value387.0222 Operating Margin-11430.935300000001 Enterprise Value92.43 Million
Current Ratio0.596 EPS Growth0.329 Quick Ratio0.414
1 Yr BETA 0.9216 52-week High/Low 1.65 / 0.26 Profit Margin-11508.2734
Operating Cash Flow Growth21.999 Free Cash Flow to Firm (FCFF) TTM -19.263 Million Free Cash Flow to Equity (FCFE) TTM-22.475 Million
Altman Z-Score-91.7005
View SEC Filings from BSGM instead.

View recent insider trading info

Funds Holding BSGM (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding BSGM

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2023-12-06:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-12-05:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2023-11-13:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-11-13:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-11-08:
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-11-07:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-11-02:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-11-02:
    Item 1.02: Termination of a Material Definitive Agreement
  • 8-K: filed on 2023-11-01:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-10-16:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 3.02: Unregistered Sales of Equity Securities
    Item 9.01: Financial Statements and Exhibits
  • Proposed Sales (Form 144)

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    LONDONER KENNETH L CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    3,908,044 2023-11-30 5

    SIECKHAUS JOHN CHIEF OPERATING OFFICER

    • Officer
    457,920 2023-11-30 3

    FLEMING GRAY CHIEF COMMERCIAL OFFICER

    • Officer
    463,556 2023-11-30 3

    FOLEY DONALD E

    • Director
    221,999 2023-08-15 3

    KLEIN JAMES L

    • Director
    299,249 2023-08-15 3

    BARRY JAMES J

    • Director
    71,249 2023-08-15 3

    GALLAGHER PATRICK JOSEPH

    • Director
    136,143 2023-08-15 3

    WEILD IV DAVID

    • Director
    114,999 2023-08-15 3

    HRKAC FREDERICK

    • Director
    94,999 2023-08-15 4

    BUHALY STEVEN J CHIEF FINANCIAL OFFICER

    • Officer
    0 2023-02-16 3

    CHAUSSY STEVE CHIEF FINANCIAL OFFICER

    • Officer
    1,051,553 2022-09-01 0

    NAVARRO SAMUEL E

    • Director
    50,000 2021-12-28 0

    ZOOK ANTHONY P.

    • Director
    50,000 2021-12-28 0

    ODONNELL JEFFREY F

    • Director
    151,629 2021-02-05 0

    PEASE MARTHA

    • Director
    29,437 2020-09-24 0

    ZELDIS JEROME B

    • Director
    0 2020-07-14 0

    FILLER ANDREW LAWRENCE

    • Director
    0 2020-04-14 0

    KOWALSKI JOHN M VP OF SALES

    • Officer
    112,000 2020-03-19 0

    MIKOLAITIS LORA

    • FILED IN ERROR; NOT 10% HOLDER
    36,500 2019-12-12 0

    TANAKA ROY T

    • Director
    0 2018-10-16 0

    FISCHER SETH H. Z.

    • Director
    60,000 2018-10-16 0

    RAFFERTY JOSEPH CHIEF COMMERCIALIZATIONOFFICER

    • Officer
    0 2018-05-04 0

    CASH GREGORY D PRESIDENT AND CEO

    • Officer
    • Director
    55,875 2016-12-14 0

    HOLZER ASHER

    • Director
    No longer subject to file 2015-10-19 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    LONDONER KENNETH L - Director - Officer CHIEF EXECUTIVE OFFICER

    2023-12-04 18:59:56 -0500 2023-11-30 A 219,700 a 2,726,720 direct 5.0167 5.0167 2 0.0 1

    FLEMING GRAY - Officer CHIEF COMMERCIAL OFFICER

    2023-12-04 19:01:39 -0500 2023-11-30 A 131,900 a 131,900 direct

    SIECKHAUS JOHN - Officer CHIEF OPERATING OFFICER

    2023-12-04 20:36:23 -0500 2023-11-30 A 92,300 a 92,300 direct

    FLEMING GRAY - Officer CHIEF COMMERCIAL OFFICER

    2023-12-05 18:15:53 -0500 2023-11-30 A 131,900 a 463,556 direct 5.0955 5.0955 2 0.0 1

    SIECKHAUS JOHN - Officer CHIEF OPERATING OFFICER

    2023-12-05 18:17:36 -0500 2023-11-30 A 92,300 a 457,920 direct 5.0955 5.0955 2 0.0 1

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    BIOSIG TECHNOLOGIES INC BSGM 2023-12-08 22:15:04 UTC -4.0543 9.3743 4300000
    BIOSIG TECHNOLOGIES INC BSGM 2023-12-08 21:45:04 UTC -4.0543 9.3743 4300000
    BIOSIG TECHNOLOGIES INC BSGM 2023-12-08 21:15:04 UTC -4.0543 9.3743 4300000
    BIOSIG TECHNOLOGIES INC BSGM 2023-12-08 20:45:04 UTC -4.0543 9.3743 4300000
    BIOSIG TECHNOLOGIES INC BSGM 2023-12-08 20:15:07 UTC -4.0543 9.3743 4300000
    BIOSIG TECHNOLOGIES INC BSGM 2023-12-08 19:45:04 UTC -4.0543 9.3743 4300000
    BIOSIG TECHNOLOGIES INC BSGM 2023-12-08 19:15:03 UTC -4.0543 9.3743 4300000
    BIOSIG TECHNOLOGIES INC BSGM 2023-12-08 18:45:03 UTC -4.0543 9.3743 4300000
    BIOSIG TECHNOLOGIES INC BSGM 2023-12-08 18:15:04 UTC -4.0543 9.3743 4300000
    BIOSIG TECHNOLOGIES INC BSGM 2023-12-08 17:45:03 UTC -4.0543 9.3743 4300000
    BIOSIG TECHNOLOGIES INC BSGM 2023-12-08 17:15:03 UTC -4.0543 9.3743 4300000
    BIOSIG TECHNOLOGIES INC BSGM 2023-12-08 16:45:05 UTC -4.0543 9.3743 4300000
    BIOSIG TECHNOLOGIES INC BSGM 2023-12-08 16:15:04 UTC -4.0543 9.3743 4300000
    BIOSIG TECHNOLOGIES INC BSGM 2023-12-08 15:45:04 UTC -4.0543 9.3743 4300000
    BIOSIG TECHNOLOGIES INC BSGM 2023-12-08 15:15:04 UTC -4.0543 9.3743 4300000
    BIOSIG TECHNOLOGIES INC BSGM 2023-12-08 14:45:04 UTC -4.0543 9.3743 4300000
    BIOSIG TECHNOLOGIES INC BSGM 2023-12-08 14:15:03 UTC -4.0543 9.3743 4300000
    BIOSIG TECHNOLOGIES INC BSGM 2023-12-08 13:45:03 UTC -4.0808 9.4008 4300000
    BIOSIG TECHNOLOGIES INC BSGM 2023-12-08 13:15:04 UTC -4.0808 9.4008 4300000
    BIOSIG TECHNOLOGIES INC BSGM 2023-12-08 12:45:05 UTC -4.0808 9.4008 4300000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund BSGM -11400.0 shares, $-5578.02 2023-09-30 N-PORT

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    WhaleWisdom Logo

    Elevate your investments